Modified Nucleosides
1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil
Quick view. Uracil nucleoside derivative with a beta-D-ribo-configured 2-O-methyl sugar and an E-configured diethoxyphosphinyl-substituted 5,6-unsaturated side chain. CAS 2095417-05-1. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil is classified as modified nucleosides (Formula C15H23N2O8P; molecular weight 390.33 g/mol).
1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil can be evaluated in chain-termination, sequencing-control or polymerase-specific substrate studies.
For 1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil, polymerase acceptance varies; absence of a 3′-OH prevents further extension after incorporation.
Names and search terms
Useful catalog search terms
- 2095417-05-1
- 5E diethoxyphosphinyl uracil nucleoside
Physicochemical data
| Nucleobase | uracil |
|---|---|
| Sugar configuration | beta-D-ribo |
| Sugar modification | 2-O-methyl |
| Alkene geometry | 5E |
| Phosphorus group | diethoxyphosphinyl |
| InChIKey | DBMYOOHATYWOQH-DAOGNUOISA-N |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Product-specific evaluation notes
Potential advantages
- Dideoxy analogs provide clear extension-stop behavior when accepted by a polymerase.
Method limitations
- Polymerase acceptance varies; absence of a 3′-OH prevents further extension after incorporation.
These points describe 1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for 1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-methyl-beta-D-ribo-hex-5-enofuranosyl]uracil be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0815 and CAS 2095417-05-1, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.